Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8660176
[patent_doc_number] => 20130041005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING NEUROPILIN INHIBITORS, AND THEIR USE FOR THE PREVENTION AND/OR TREATMENT OF ANGIOGENIC DISORDERS AND CANCERS'
[patent_app_type] => utility
[patent_app_number] => 13/655870
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14574
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13655870
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/655870 | PHARMACEUTICAL COMPOSITIONS COMPRISING NEUROPILIN INHIBITORS, AND THEIR USE FOR THE PREVENTION AND/OR TREATMENT OF ANGIOGENIC DISORDERS AND CANCERS | Oct 18, 2012 | Abandoned |
Array
(
[id] => 10906194
[patent_doc_number] => 20140309207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'NOVEL SPIROINDOLINE COMPOUND, AND MEDICINAL AGENT COMPRISING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/351914
[patent_app_country] => US
[patent_app_date] => 2012-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 83470
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351914
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/351914 | Spiroindoline compound, and medicinal agent comprising same | Oct 17, 2012 | Issued |
Array
(
[id] => 9245579
[patent_doc_number] => 08609861
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-12-17
[patent_title] => 'Hexaaza [3.3.3] propellane compounds as key intermediates for new molecular explosives and a method for preparing the same'
[patent_app_type] => utility
[patent_app_number] => 13/652281
[patent_app_country] => US
[patent_app_date] => 2012-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3365
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13652281
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/652281 | Hexaaza [3.3.3] propellane compounds as key intermediates for new molecular explosives and a method for preparing the same | Oct 14, 2012 | Issued |
Array
(
[id] => 10954666
[patent_doc_number] => 20140357687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'Pyrazol-3-ones That Activate Pro-apoptotic BAX'
[patent_app_type] => utility
[patent_app_number] => 14/350847
[patent_app_country] => US
[patent_app_date] => 2012-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 29360
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350847
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350847 | Pyrazol-3-ones that activate pro-apoptotic BAX | Oct 10, 2012 | Issued |
Array
(
[id] => 9699632
[patent_doc_number] => 20140249318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-04
[patent_title] => 'THERAPEUTIC AGENT AND PREVENTIVE AGENT FOR DEMYELINATING DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/349430
[patent_app_country] => US
[patent_app_date] => 2012-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2500
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349430
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/349430 | THERAPEUTIC AGENT AND PREVENTIVE AGENT FOR DEMYELINATING DISEASE | Oct 9, 2012 | Abandoned |
Array
(
[id] => 10162499
[patent_doc_number] => 09193717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-24
[patent_title] => 'Mineralocorticoid receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 14/350888
[patent_app_country] => US
[patent_app_date] => 2012-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15387
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350888
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350888 | Mineralocorticoid receptor antagonists | Oct 7, 2012 | Issued |
Array
(
[id] => 9895995
[patent_doc_number] => 20150051193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'PI-kinase Inhibitors with Broad Spectrum Anti-Infective Activity'
[patent_app_type] => utility
[patent_app_number] => 14/348864
[patent_app_country] => US
[patent_app_date] => 2012-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21350
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348864
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/348864 | PI-kinase inhibitors with broad spectrum anti-infective activity | Oct 4, 2012 | Issued |
Array
(
[id] => 8638225
[patent_doc_number] => 20130030028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'DESFERRITHIOCIN POLYETHER ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 13/631025
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8397
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13631025
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/631025 | Desferrithiocin polyether analogues | Sep 27, 2012 | Issued |
Array
(
[id] => 9786398
[patent_doc_number] => 20140303218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'Nitrogen Mustard Derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/347397
[patent_app_country] => US
[patent_app_date] => 2012-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11419
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14347397
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/347397 | Nitrogen mustard derivatives | Sep 26, 2012 | Issued |
Array
(
[id] => 9656315
[patent_doc_number] => 20140227320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'ANTI-VIRAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/348516
[patent_app_country] => US
[patent_app_date] => 2012-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19076
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348516
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/348516 | Anti-viral compounds | Sep 26, 2012 | Issued |
Array
(
[id] => 9799584
[patent_doc_number] => 20150011528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/346506
[patent_app_country] => US
[patent_app_date] => 2012-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88211
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346506
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/346506 | PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Sep 20, 2012 | Abandoned |
Array
(
[id] => 9450214
[patent_doc_number] => 20140121383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'PROCESS FOR THE PREPARATION OF BENDAMUSTINE HYDROCHLORIDE'
[patent_app_type] => utility
[patent_app_number] => 13/623536
[patent_app_country] => US
[patent_app_date] => 2012-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6308
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13623536
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/623536 | Process for the preparation of bendamustine hydrochloride | Sep 19, 2012 | Issued |
Array
(
[id] => 10975647
[patent_doc_number] => 20140378682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'PROCESSES AND INTERMEDIATES FOR PREPARING RIVAROXABAN'
[patent_app_type] => utility
[patent_app_number] => 14/343785
[patent_app_country] => US
[patent_app_date] => 2012-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12318
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343785
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343785 | PROCESSES AND INTERMEDIATES FOR PREPARING RIVAROXABAN | Sep 9, 2012 | Abandoned |
Array
(
[id] => 9656220
[patent_doc_number] => 20140227225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'HCV Helicase Inhibitors and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/343465
[patent_app_country] => US
[patent_app_date] => 2012-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32207
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343465
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343465 | HCV helicase inhibitors and methods of use thereof | Sep 6, 2012 | Issued |
Array
(
[id] => 8829244
[patent_doc_number] => 20130130289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'COMPOUNDS AND METHODS FOR ASSAYING REDOX STATE OF METABOLICALLY ACTIVE CELLS AND METHODS FOR MEASURING NAD(P)/NAD(P)H'
[patent_app_type] => utility
[patent_app_number] => 13/600579
[patent_app_country] => US
[patent_app_date] => 2012-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 24048
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13600579
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/600579 | Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H | Aug 30, 2012 | Issued |
Array
(
[id] => 9339847
[patent_doc_number] => 20140066629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'PROCESS FOR THE PREPARATION OF AROMATIC AZOLE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/597988
[patent_app_country] => US
[patent_app_date] => 2012-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6120
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13597988
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/597988 | PROCESS FOR THE PREPARATION OF AROMATIC AZOLE COMPOUNDS | Aug 28, 2012 | Abandoned |
Array
(
[id] => 10115656
[patent_doc_number] => 09150527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-06
[patent_title] => 'Metalloenzyme inhibitor compounds'
[patent_app_type] => utility
[patent_app_number] => 14/342323
[patent_app_country] => US
[patent_app_date] => 2012-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13665
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342323
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/342323 | Metalloenzyme inhibitor compounds | Aug 26, 2012 | Issued |
Array
(
[id] => 8638160
[patent_doc_number] => 20130029964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => '[5, 6] HETEROCYCLIC COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/595608
[patent_app_country] => US
[patent_app_date] => 2012-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36949
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13595608
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/595608 | [5, 6] HETEROCYCLIC COMPOUND | Aug 26, 2012 | Abandoned |
Array
(
[id] => 10975386
[patent_doc_number] => 20140378415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'ISOTHIAZOLINE DERIVATIVES AS INSECTICIDAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/344123
[patent_app_country] => US
[patent_app_date] => 2012-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 161538
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344123
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/344123 | Isothiazoline derivatives as insecticidal compounds | Aug 26, 2012 | Issued |
Array
(
[id] => 9643552
[patent_doc_number] => 20140221665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'LUMINESCENT SUBSTRATE FOR LUCIFERASE'
[patent_app_type] => utility
[patent_app_number] => 14/240144
[patent_app_country] => US
[patent_app_date] => 2012-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10645
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240144
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/240144 | Luminescent substrate for luciferase | Aug 21, 2012 | Issued |